We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » PDUFA IV Would Strengthen Drug Safety System, PhRMA CEO Says
PDUFA IV Would Strengthen Drug Safety System, PhRMA CEO Says
March 30, 2007
While the FDA’s recommendations for the reauthorization of the Prescription Drug User Fee Act (PDUFA) would cover the agency’s needs, Congress should consider appropriating more funds so the agency does not rely so much on user fees, PhRMA CEO Billy Tauzin said.